Suspension of trading
Comparison Chart Arcellx, Inc.
Stocks
ACLX
US03940C1009
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.07 USD | +0.03% |
|
-.--% | +76.49% |
| 05-07 | Gilead Sciences Expects Loss This Year on Acquired R&D Expenses | DJ |
| 05-07 | Gilead raises 2026 sales forecast, flags profit hit from acquisitions | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCELLX, INC. | Other Biotechnology & Medical Research | +0.03% | -.--% | +76.49% | +61.75% | - | 6.75B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ACLX Stock
- Charts Arcellx, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
